login
Become a member
Quick Registration
Full Registration Benefits -
Free Homepages for Doctors
Free Homepages for Hospitals
Free Homepages for Medical Conference
Free Homepages for NGO's
Personal Health Record Creation
Access to all Medical Slides
Access to all Jobs & Products Sale
Surgery May be More Effective Than Watchful Waiting in Prostate Cancer
Prostate cancer is a cancer that develops in the prostate gland, commonly affecting males above the age of fifty years. The prostate is a small, walnut-sized structure. It forms part of the male reproductive system. There are four modalities of management of a cancer of the prostate: Watchful waiting, surgery, radiation therapy, and hormone therapy.
Radical-prostatectomy refers to surgical removal of the prostate. A recent study compared radical-prostatectomy with watchful waiting, i.e. close observation of changing symptoms and disease progression rather than initiating treatments all of a sudden. The study group was divided into two, one receiving surgery and the other being observed (watchful waiting). A total of 347 men were assigned to the radical-prostatectomy group, and 348 to the watchful-waiting group. ‘There continues to be a significant reduction in the rate of death from any cause, the rate of death from prostate cancer, and the risk of metastases in the radical-prostatectomy group as compared with the watchful-waiting group’, quote the authors. The results were published in the New England Journal of Medicine, a leading medical journal.
The benefit was obvious among men younger than 65 years of age. Whether the benefit extends to older men is still unclear. The benefit of radical prostatectomy continued to be seen beyond 9 years. In some men, the tumor grows further, thus developing ‘extracapsular tumor growth’. Such men were found to benefit from adjuvant, local or systemic treatment.
The current study that favors surgical resection of prostate is not conclusive though relevant. The observations are sharp, but further scrutiny is required.
Source: Anna Bill-Axelson, M.D., Ph.D., Lars Holmberg, M.D., Ph.D., Mirja Ruutu, M.D., Ph.D., Hans Garmo, Ph.D., Jennifer R. Stark, Sc.D., Christer Busch, M.D., Ph.D., Stig Nordling, M.D., Ph.D., Michael Häggman, M.D., Ph.D., Swen-Olof Andersson, M.D., Ph.D., Stefan Bratell, M.D., Ph.D., Anders Spĺngberg, M.D., Ph.D., Juni Palmgren, Ph.D., Gunnar Steineck, M.D., Ph.D., Hans-Olov Adami, M.D., Ph.D., and Jan-Erik Johansson, M.D., Ph.D. for the SPCG-4 Investigators;N Engl J Med 2011; 364:1708-1717.
Source-Medindia
|
|
More News on: Prostate Cancer, Cancer and Homeopathy, Check your prostate gland, Prostatitis Symptom Score Calculator, Trans-Urethral Resection of the Prostate, Prostate Cancer Facts, Cancer Facts, Cancer, Tattoos A Body Art, Hematuria
 Comment & Contribute
|
Medwonders Health Network
- Health News Index
|
|
 | Quiz on Cancer Looking for information on cancer? Go through medindia's Cancer quiz. 
|
- News Quick Links
 |
Cancer
Complete Medindia Resources
|
| News Categories: |
| » | Drug for Irregular Heartbeat Gets Green Signal |
| » | Schizophrenia Drug Differentiates Cancer Stem Cells into Less Threatening Cells |
| » | Docs Who Seldom Meet Drug Reps Continue to Prescribe Drugs With FDA “Black Box” Warnings |
| » | Revision in Quality Standards for Heparin |
| » | Acne Drug Users At High Risk of Developing Eye Infections |
| More Drug News | |
|
